Ophthalmic findings in a patient with CD8-positive T cell lymphoma and a hydroa vacciniforme-like eruption

2010 ◽  
Vol 94 (9) ◽  
pp. 1266-1267 ◽  
Author(s):  
K. J. Zamecki ◽  
A. H. Friedman ◽  
E. L. Raab
Keyword(s):  
T Cell ◽  
Cell Lymphoma ◽  
T Cell Lymphoma ◽  
Hydroa Vacciniforme

scholarly journals Hydroa vacciniforme-like cutaneous T-cell lymphoma

2014 ◽  
Vol 59 (1) ◽  
pp. 91 ◽  
Author(s):  
Qiu-Xia Chen ◽  
Shun-Fan Li ◽  
Wen Li ◽  
Jian-Qiang Shi
Keyword(s):  
T Cell ◽  
Cell Lymphoma ◽  
T Cell Lymphoma ◽  
Cutaneous T Cell Lymphoma ◽  
Hydroa Vacciniforme

scholarly journals Hydroa Vacciniforme–Like Lymphoproliferative Disorder With Progression to EBV+ Cytotoxic Peripheral T-Cell Lymphoma

2020 ◽  
Vol 42 (9) ◽  
pp. 714-716 ◽  
Author(s):  
Kirill A. Lyapichev ◽  
Narittee Sukswai ◽  
Xiaohong I. Wang ◽  
Joseph D. Khoury ◽  
L. Jeffrey Medeiros
Keyword(s):  
T Cell ◽  
Lymphoproliferative Disorder ◽  
Cell Lymphoma ◽  
T Cell Lymphoma ◽  
Peripheral T Cell Lymphoma ◽  
Hydroa Vacciniforme

scholarly journals Hydroa vacciniforme-like lymphoproliferative disorder in Korea

2020 ◽  
Vol 10 (1) ◽  
Author(s):  
Byeol Han ◽  
Keunyoung Hur ◽  
Jungyoon Ohn ◽  
Tae Min Kim ◽  
Yoon Kyung Jeon ◽  
...  
Keyword(s):  
T Cell ◽  
Natural Killer ◽  
Lymphoproliferative Disorder ◽  
Cell Lymphoma ◽  
T Cell Lymphoma ◽  
Aggressive Lymphoma ◽  
Natural Killer T Cell ◽  
Hydroa Vacciniforme ◽  
Killer T Cell ◽  
Natural Killer T

Abstract Hydroa vacciniforme-like lymphoproliferative disorder (HVLPD) is a rare Epstein–Barr virus (EBV)-associated lymphoproliferative disease. The disease course of HVLPD varies from an indolent course to progression to aggressive lymphoma. We investigated the characteristics of HVLPD in Korean patients. HVLPD patients at Seoul National University Hospital between 1988 and 2019 were retrospectively analyzed. This study included 26 HVLPD patients who all presented with recurrent papulovesicular and necrotic eruption on the face, neck, and extremities. EBV was detected from the skin tissues of all patients. HVLPD was diagnosed during childhood (age < 18 years) in seven patients (26.9%) and in adulthood (age ≥ 18 years) in 19 cases (73.1%). The median age at diagnosis was 24.0 years (range 7–70 years). HVLPD has various clinical courses, from an indolent course to progression to systemic lymphoma. Fourteen patients (53.8%) developed lymphoma: systemic EBV-positive T-cell lymphoma (n = 9, 34.6%); extranodal natural killer/T-cell lymphoma, nasal type (n = 3, 11.5%); aggressive natural killer/T-cell leukemia (n = 1, 3.8%); and EBV-positive Hodgkin lymphoma (n = 1, 3.8%). Mortality due to HVLPD occurred in five patients (26.3%) in the adult group, while it was one patient (14.3%) in the child group. As lymphoma progression and mortality occur not only in childhood but also in adulthood, adult-onset cases may need more careful monitoring.

A Rare Case of Hydroa Vacciniforme–Like Cutaneous T-Cell Lymphoma Presenting Mimicking Herpes Simplex in an Adult

2013 ◽  
Vol 35 (5) ◽  
pp. 617-618 ◽  
Author(s):  
Tingting Wang ◽  
Lin Wang ◽  
Lin Xiong ◽  
Min Han ◽  
Weiping Liu ◽  
...  
Keyword(s):  
Herpes Simplex ◽  
T Cell ◽  
Rare Case ◽  
Cell Lymphoma ◽  
T Cell Lymphoma ◽  
Cutaneous T Cell Lymphoma ◽  
Hydroa Vacciniforme

Hydroa vacciniforme-like primary cutaneous CD8-positive T-cell lymphoma

2002 ◽  
Vol 147 (3) ◽  
pp. 587-591 ◽  
Author(s):  
H-H. Chen ◽  
C-H. Hsiao ◽  
H-C. Chiu
Keyword(s):  
T Cell ◽  
Cell Lymphoma ◽  
T Cell Lymphoma ◽  
Hydroa Vacciniforme
Sign in / Sign up

Export Citation Format

Share Document